| Seagen | Pfizer | $43000m | Mar, 2023 | Acquisition |
|---|---|---|---|---|
| Catalent | Novo Holdings | $16500m | Feb, 2024 | Acquisition |
| Karuna Therapeutics | Bristol-Myers Squibb | $14000m | Dec, 2023 | Acquisition |
| Three Fill-Finish Sites - Novo Holdings | Novo Nordisk | $11000m | Feb, 2024 | Asset Transaction |
| Prometheus Biosciences | Merck | $10800m | Apr, 2023 | Acquisition |